Tools & Calculators
Sector: Pharmaceuticals & Biotechnology
|Large Cap
Biocon Ltd.
₹369.25
Invest in BIOCON with up to 3.57x margin.
Trade with MTF₹362.00
₹371.90
₹299.00
₹424.95
Markets Today
Historical Performance
Indicator | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|
| Total Revenue | 621.30 | 583.30 | 537.10 | 643.80 | 562.80 |
| Operating Expense | 548 | 530.40 | 516.50 | 581.80 | 531.50 |
| Operating Profit | 73.30 | 52.90 | 20.60 | 62 | 31.30 |
| Depreciation | 34 | 33.80 | 33.30 | 33 | 33.80 |
| Interest | 2.30 | 67.20 | 56.20 | 56.70 | 65.30 |
| Tax | -8.10 | 14.80 | 0.70 | 13.80 | 19.90 |
| Net Profit | -76.40 | 70.90 | -8.30 | 21.20 | 584 |
₹369.25
↗ Bullish Moving Average
0
↘ Bearish Moving Average
16
\
| Held By | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|
| Promoter | 60.6 | 60.6 | 60.6 | 54.4 | 54.4 | 54.4 |
| FII | 5.9 | 5.7 | 5.7 | 6 | 6.6 | 7.4 |
| DII | 14.5 | 15.3 | 15.7 | 22.9 | 22.1 | 21.7 |
| Public | 18.7 | 18.1 | 17.8 | 16.5 | 16.7 | 16.3 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 13.68 L | 34.13 L | 40.07% |
| Week | 18.37 L | 35.73 L | 51.41% |
| 1 Month | 20.71 L | 37.64 L | 55.03% |
| 6 Month | 16.85 L | 35.29 L | 47.76% |
Benjamin Graham Value Screen
Mid-range Performer (DVM)
Relative Outperformance versus Industry over 1 Month
Rising Net Cash Flow and Cash from Operating activity
Relative Outperformance versus Industry over 1 Year
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Growth in Net Profit with increasing Profit Margin (QoQ)
Increasing profits every quarter for the past 2 quarters
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Companies with Zero Promoter Pledge
Stocks Outperforming their Industry Price Change in the Quarter
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 04 Jul, 2025 | 0.5 | FINAL | 04 Jul, 2025 | Equity Share |
| 05 Jul, 2024 | 0.5 | FINAL | 05 Jul, 2024 | Equity Share |
| 07 Jul, 2023 | 1.5 | FINAL | 07 Jul, 2023 | Equity Share |
| 30 Jun, 2022 | 0.5 | FINAL | 01 Jul, 2022 | Equity Share |
| 18 Jul, 2019 | 0.5 | FINAL | 19 Jul, 2019 | Equity Share |
| 19 Jul, 2018 | 1 | FINAL | 20 Jul, 2018 | Equity Share |
| 20 Jul, 2017 | 1 | FINAL | Equity Share | |
| 17 Mar, 2016 | 5 | INTERIM | 19 Mar, 2016 | Equity Share |
| 09 Apr, 2015 | 5 | INTERIM | 10 Apr, 2015 | Equity Share |
| 10 Jul, 2014 | 5 | FINAL | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹673.60 | ₹967.85 | ₹1,596.80 | ₹1,999.70 | ₹1,725.10 | ₹1,035.50 |
| % Change | 2.64% | -0.43% | 0.08% | -0.30% | 1.71% | 4.31% |
| Revenue TTM (₹ Cr) | ₹1,996.59 | ₹2,169.86 | ₹8,850.08 | ₹13,914.08 | ₹6,112.77 | ₹6,721.63 |
| Net Profit TTM (₹ Cr) | ₹484.66 | ₹332.94 | ₹869.92 | ₹1,779.35 | ₹847.18 | ₹843.32 |
| PE TTM | 76.10 | 61.80 | 34.80 | 46.50 | 33.00 | 63.50 |
| 1 Year Return | 15.13 | 27.75 | 48.78 | -17.28 | 6.51 | 61.84 |
| ROCE | 26.88 | 12.51 | 20.80 | 13.27 | 11.43 | 11.82 |
Alkem Laboratories Ltd.
₹ 5264.00
-0.66%
Divi's Laboratories Ltd.
₹ 5912.50
-0.58%
Ajanta Pharma Ltd.
₹ 2828.90
+0.85%
Zydus Lifesciences Ltd.
₹ 873.60
+0.28%
Glenmark Pharmaceuticals Ltd.
₹ 2119.50
-0.57%
Aurobindo Pharma Ltd.
₹ 1344.40
+3.07%
Sun Pharmaceutical Industries Ltd.
₹ 1729.90
-1.55%
Ipca Laboratories Ltd.
₹ 1561.90
-2.45%
J B Chemicals & Pharmaceuticals Ltd.
₹ 2009.60
-2.65%
AstraZeneca Pharma India Ltd.
₹ 7867.00
+1.31%
GlaxoSmithKline Pharmaceuticals Ltd.
₹ 2335.60
+2.30%
Pfizer Ltd.
₹ 4833.30
+2.39%
Abbott India Ltd.
₹ 26405.00
+1.89%
Torrent Pharmaceuticals Ltd.
₹ 4153.40
-1.58%
Lupin Ltd.
₹ 2281.20
-1.41%
Dr. Reddy's Laboratories Ltd.
₹ 1228.00
-2.14%
Cipla Ltd.
₹ 1201.60
-1.85%
By signing up I certify terms, conditions & privacy policy